Gemcitabine combination therapy

Details Gemcitabine combination therapy Gemcitabine combination therapy

A - Human Necessities

61

K

A61K 31/7068 (2006.01) A61K 38/15 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2649877

The present invention provides compositions and methods for the treatment of cell proliferative disorders using at least one DAC inhibitor and gemcitabine.

La présente invention concerne des compositions et des procédés pour le traitement de troubles de prolifération cellulaire utilisant au moins un inhibiteur de DAC et la gemcitabine.

Affiliated with

Also associated with

Rating

Gemcitabine combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gemcitabine combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gemcitabine combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1820131